The House passed a minibus funding package on Tuesday (June 25) that aims to give FDA a $184 million funding boost over fiscal 2019 levels and redirect $100,000 from the agency’s general purpose funding towards its efforts to establish a safe, lawful level of cannabidiol (CBD) to be allowed in food and dietary supplements. It is still unclear when, or if, the $5.86 billion FDA funding bill will be signed into law, as there are obstacles still standing in the...